HCA Healthcare (NYSE:HCA) Price Target Increased to $165.00 by Analysts at Truist

HCA Healthcare (NYSE:HCA) had its price target lifted by research analysts at Truist from $150.00 to $165.00 in a report issued on Wednesday, The Fly reports. The firm presently has a “buy” rating on the stock. Truist’s price objective suggests a potential upside of 19.58% from the company’s previous close.

Other analysts also recently issued reports about the stock. SunTrust Banks boosted their price target on shares of HCA Healthcare from $130.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, July 23rd. Piper Sandler lifted their price objective on shares of HCA Healthcare from $132.00 to $138.00 and gave the stock a “neutral” rating in a research note on Thursday, July 23rd. Mizuho lifted their price objective on shares of HCA Healthcare from $136.00 to $145.00 and gave the stock a “buy” rating in a research note on Thursday, July 23rd. Raymond James lifted their price objective on shares of HCA Healthcare from $130.00 to $140.00 and gave the stock an “outperform” rating in a research note on Thursday, July 23rd. Finally, UBS Group lowered their price objective on shares of HCA Healthcare from $138.00 to $137.00 and set a “buy” rating on the stock in a research note on Thursday, June 11th. One analyst has rated the stock with a sell rating, three have given a hold rating and sixteen have assigned a buy rating to the company. HCA Healthcare currently has a consensus rating of “Buy” and an average price target of $148.28.

Shares of HCA stock traded up $2.18 during midday trading on Wednesday, reaching $137.98. 17,493 shares of the company were exchanged, compared to its average volume of 2,511,703. HCA Healthcare has a 12 month low of $58.38 and a 12 month high of $151.97. The company has a market cap of $45.90 billion, a P/E ratio of 14.25, a PEG ratio of 1.20 and a beta of 1.40. The company’s 50 day moving average price is $132.59 and its two-hundred day moving average price is $111.31. The company has a debt-to-equity ratio of 54.19, a quick ratio of 0.95 and a current ratio of 1.09.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $3.23 EPS for the quarter, topping analysts’ consensus estimates of ($0.94) by $4.17. HCA Healthcare had a net margin of 6.67% and a negative return on equity of 589.47%. The company had revenue of $11.07 billion for the quarter, compared to the consensus estimate of $10.44 billion. During the same period in the previous year, the firm earned $2.21 EPS. HCA Healthcare’s revenue was down 12.2% on a year-over-year basis. As a group, sell-side analysts predict that HCA Healthcare will post 10.12 earnings per share for the current year.

In related news, insider A Bruce Moore, Jr. sold 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $133.73, for a total transaction of $2,005,950.00. Following the transaction, the insider now directly owns 88,626 shares of the company’s stock, valued at $11,851,954.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP P. Martin Paslick sold 227 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $134.97, for a total transaction of $30,638.19. Following the transaction, the senior vice president now directly owns 2,621 shares in the company, valued at $353,756.37. The disclosure for this sale can be found here. Insiders have sold 15,481 shares of company stock worth $2,070,363 over the last ninety days. 1.80% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Two Sigma Advisers LP lifted its stake in HCA Healthcare by 46.8% in the second quarter. Two Sigma Advisers LP now owns 817,436 shares of the company’s stock valued at $79,340,000 after acquiring an additional 260,500 shares during the last quarter. Schonfeld Strategic Advisors LLC lifted its stake in HCA Healthcare by 421.5% in the second quarter. Schonfeld Strategic Advisors LLC now owns 44,288 shares of the company’s stock valued at $4,299,000 after acquiring an additional 35,795 shares during the last quarter. Reliant Investment Management LLC acquired a new stake in shares of HCA Healthcare in the second quarter worth $2,732,000. AdvisorNet Financial Inc acquired a new stake in shares of HCA Healthcare in the second quarter worth $84,000. Finally, Quadrature Capital Ltd lifted its stake in shares of HCA Healthcare by 250.4% in the second quarter. Quadrature Capital Ltd now owns 53,447 shares of the company’s stock worth $5,181,000 after buying an additional 38,192 shares during the last quarter. Hedge funds and other institutional investors own 68.28% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: What is an economic bubble?

The Fly

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply